Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV ketamine versus fentanyl sedation in pediatric dentistry
IRCT20140106016106N6Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2017
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ketamine, fentanyl, midazolam and atropine in Procedural anxiety (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Sedative effect of IV fentanyl/atropine/midazolam, Sedative effect of IV ketamine/atropine/midazolam and 2 more. Started Nov 2017; status: completed.
02
Drugs
ketaminefentanylmidazolamatropine
03
Conditions
Procedural anxiety
Beyond the preview
Go deeper on IRCT20140106016106N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140106016106N6.